{"transactions":[{"id":3352275,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-12-04T22:19:25.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":691000,"derivative":{"underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001161697-19-000514","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169719000514/form4.xml","form_type":"4"}},{"id":3352274,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2019-12-04T22:19:25.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":132000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."}],"balance_after":647000,"derivative":{"exercise_price":4.64,"expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001161697-19-000514","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169719000514/form4.xml","form_type":"4"}},{"id":3720747,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:46:22.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":38334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":515000,"derivative":{"exercise_price":2.24,"exercise_date":"2021-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":38334},"source":{"system":"sec-edgar","filing":"0001161697-18-000620","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000620/form4.xml","form_type":"4"}},{"id":3720746,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:46:22.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":38333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":476666,"derivative":{"exercise_price":2.24,"exercise_date":"2020-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":38333},"source":{"system":"sec-edgar","filing":"0001161697-18-000620","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000620/form4.xml","form_type":"4"}},{"id":3720745,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:46:22.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":38333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":438333,"derivative":{"exercise_price":2.24,"exercise_date":"2019-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":38333},"source":{"system":"sec-edgar","filing":"0001161697-18-000620","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000620/form4.xml","form_type":"4"}},{"id":4014996,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right To Purchase)","published_at":"2018-03-05T13:29:14.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 90,000 shares of Common Stock, will become exercisable on March 1, 2019, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":90000,"derivative":{"exercise_price":14.98,"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001127602-18-009817","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760218009817/form4.xml","form_type":"4"}},{"id":4569336,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":153371,"kind":"person","name":"BRENNAN DANIEL","position":1,"cik":"0001657999","reported_name":"BRENNAN DANIEL","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right To Purchase)","published_at":"2016-11-02T17:44:06.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":150000,"price":10.09,"value":1513500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on October 17, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":10.09,"expiration_date":"2026-10-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001127602-16-065820","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000112760216065820/form4.xml","form_type":"4"}}]}